Loading…
Operates in Pharma — Production. Per the activity note to the FY2024 annual report, the company manufactures pharmaceutical preparations.
| Line item | 2018 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|
| 1,450 | 1,885 | 1,289 | 1,641 | +2.1% | |
| Total COGS | 272 | 267 | 179 | 272 | -0.0% |
| Gross Profit | 1,178 | 1,618 | 1,110 | 1,369 | +2.5% |
| Gross Margin | 81.2% | 85.8% | 86.1% | 83.4% | |
| 508 | 676 | 540 | 611 | +3.1% | |
| EBITDA | 670 | 942 | 570 | 758 | +2.1% |
| EBITDA Margin | 46.2% | 50.0% | 44.2% | 46.2% | |
| Total D&A | 5 | 0 | 22 | 29 | +32.8% |
| EBIT / Operating Income | 665 | 942 | 548 | 729 | +1.6% |
| Total Interest Income | 0 | 53 | 96 | 10 | -55.6% |
| Total Other Income | 0 | 0 | 6 | 214 | nmf |
| Profit Before Tax | 665 | 995 | 651 | 526 | -3.8% |
| Total Income Tax | 37 | 223 | 176 | 96 | +17.0% |
| Net Profit / (Loss) | 627 | 772 | 475 | 430 | -6.1% |
| Net Margin | 43.2% | 41.0% | 36.8% | 26.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.